Regulation of programmed -1 ribosomal frameshifting by micro-RNAs
micro-RNA 对程序性 -1 核糖体移码的调节
基本信息
- 批准号:9278237
- 负责人:
- 金额:$ 29.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-25 至 2019-05-31
- 项目状态:已结题
- 来源:
- 关键词:3-DimensionalAIDS/HIV problemAddressAffectAnimalsAreaBase PairingBasic ScienceBiological AssayBiological ModelsCCR5 geneCell LineCell physiologyCellsCellular biologyCis-Acting SequenceCodon NucleotidesCollaborationsComplexComputer SimulationComputing MethodologiesCytokine ReceptorsDataDatabasesDefectDevelopmentDevelopmental BiologyElementsEukaryotaFeedbackFoundationsGene ExpressionGenetic CodeGenomeGlobal ChangeHIV-1HealthHumanImmune responseImmune signalingImmunologyIn VitroJAK2 geneLaboratoriesLinkMathematicsMediatingMessenger RNAMethodsMicroRNAsModelingMolecularMolecular BiologyPathway interactionsPlayPreclinical Drug EvaluationProtein Tyrosine KinaseProteinsPublishingRNAReading FramesRegulationReporterResearchResolutionRibosomal FrameshiftingRibosomesRoleSequence AnalysisSeriesSignal TransductionSingle Nucleotide PolymorphismStructureStructure-Activity RelationshipT-LymphocyteTechnologyTelomere MaintenanceTerminator CodonTestingTranslational ResearchUntranslated RNAWorkYeastsbasebiophysical techniquescytokinedesigndrug developmentfrontierinnovationmRNA DecaymRNA Transcript Degradationnext generationnovelprematureprotein expressionresponseribosome profilingsmall molecule therapeuticsstructural biologytherapeutic targetunpublished worksvirology
项目摘要
PROJECT SUMMARY/ABSTRACT
Since the genetic code was elucidated in the early 1960's, it has been assumed that mRNAs are always
decoded in three base codons, that any deviation from this fundamental rule must be erroneous and thus,
deleterious. However, over the past decade, we have shown that a significant fraction of cellular mRNAs
harbor cis-acting sequence elements that direct elongating ribosomes to shift reading frame by one base in the
5' (-1) direction. In cellular mRNAs, such Programmed -1 Ribosomal Frameshift (-1 PRF) signals direct
ribosomes to premature termination codons where they become substrates for rapid degradation through the
Nonsense-Mediated mRNA Decay (NMD) pathway, resulting in decreased expression of the proteins encoded
by these mRNAs. Importantly, rates of mRNA degradation are proportional to rates of -1 PRF, a relationship
that is conserved in eukaryotes from yeast to humans. Observations from yeast to humans that global changes
in -1 PRF rates are deleterious to cellular function suggested that regulation of -1 PRF must be sequence-
specific. Recently, we discovered that this is achieved through the interactions between -1 PRF signals and
miRNAs. These findings have initiated a completely new avenue of research by establishing -1 PRF on cellular
mRNAs, and its regulation by miRNAs as a new, fundamental paradigm in gene expression. This proposal
seeks to deepen our understanding of the molecular mechanisms underlying regulation of -1 PRF in human
cells. The well-defined Jurkat human T-cell line and a focus on -1 PRF signals embedded in mRNAs encoding
cytokine receptors and a critical cytokine-responsive tyrosine kinase provides a model system to address a
series of questions ranging from basic molecular and structural biology to regulation and control of the
acquired immune response. Aim 1 of this proposal seeks to confirm -1 PRF promoted by sequences identified
in the mRNAs encoding IL2Rγ, IL7Rα, and JAK2, characterize the effects of SNPs on -1 PRF, and develop
the next generation PRF technology. Aim 2 will identify and validate miRNAs that naturally interact with
these -1 PRF signals, and will test an autoregulatory feedback loop model of -1 PRF. Aim 3 is oriented
towards characterizing the effects of miRNAs on gene expression and RNA structure. By the end of the
proposed studies, we will have 1) deepened our understanding of this new paradigm gene expression control,
2) identified specific miRNAs that are used by T-cells to control their responses to important cytokines, and 3)
established new rules describing mRNA/miRNA atomic scale structural interactions. These studies will
immediately impact many fields including basic molecular and cell biology, and more applied fields including
immunology and HIV/AIDS, and will lay the foundation for the design and discovery of small molecule
therapeutics targeted to specific -1 PRF signals.
项目摘要/摘要
由于遗传密码在1960年代初期被阐明,因此人们认为mRNA始终是
在三个基本密码子中解码,任何偏离此基本规则都必须是错误的,因此
有害。但是,在过去的十年中,我们已经表明了很大一部分细胞mRNA
携带顺式作用序列元件,将核糖体伸长以将阅读框移到一个基础上
5'(-1)方向。在细胞mRNA中,此类编程的-1核糖体移状(-1 PRF)信号直接
核糖体到过早终止密码子,它们成为通过
废话介导的mRNA衰变(NMD)途径,导致蛋白质的表达降低
通过这些mRNA。重要的是,mRNA降解的速率与-1 prf的速率成正比,关系
从酵母到人类的真核生物中,这是保守的。从酵母到人类的观察,全球变化
在-1中,将PRF速率删除到细胞功能表明-1的调节必须是序列 -
具体的。最近,我们发现这是通过-1 prf信号与
mirnas。这些发现通过建立-1 prf的细胞来启动了全新的研究途径
mRNA及其由miRNA作为基因表达的新的基本范式的调节。这个建议
旨在加深我们对人类-1 PRF基本机制的分子机制的理解
细胞。定义明确的Jurkat人类T细胞系列,重点是嵌入MRNA编码中的-1 PRF信号
细胞因子受体和关键的细胞因子响应性酪氨酸激酶提供了一种模型系统来解决
一系列问题,从基本分子和结构生物学到调节和控制
获得的免疫响应。本提案的目标1旨在确认-1 prf通过确定的序列促进
在编码IL2Rγ,IL7Rα和JAK2的mRNA中,表征了SNP对-1 PRF的影响,并发展
下一代PRF技术。 AIM 2将识别和验证自然相互作用的miRNA
这些-1个PRF信号,并将测试-1 PRF的自动调节反馈循环模型。 AIM 3是定向的
旨在表征miRNA对基因表达和RNA结构的影响。到结束
拟议的研究,我们将有1)加深对这种新范式基因表达控制的理解,
2)鉴定出T细胞用于控制其对重要细胞因子的反应的特定miRNA,3)
建立了描述mRNA/miRNA原子尺度结构相互作用的新规则。这些研究会
立即影响许多领域,包括基本分子和细胞生物学,以及更多应用领域
免疫学和艾滋病毒/艾滋病,并将为小分子的设计和发现奠定基础
治疗针对特定-1 PRF信号。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jonathan D Dinman其他文献
Jonathan D Dinman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jonathan D Dinman', 18)}}的其他基金
Regulation of programmed -1 ribosomal frameshifting by micro-RNAs
micro-RNA 对程序性 -1 核糖体移码的调节
- 批准号:
9006443 - 财政年份:2015
- 资助金额:
$ 29.68万 - 项目类别:
Regulation of programmed -1 ribosomal frameshifting by micro-RNAs
micro-RNA 对程序性 -1 核糖体移码的调节
- 批准号:
9150632 - 财政年份:2015
- 资助金额:
$ 29.68万 - 项目类别:
X-linked Dyskeratosis Congenita and ribosomal frameshifting
X连锁先天性角化不良和核糖体移码
- 批准号:
8761841 - 财政年份:2014
- 资助金额:
$ 29.68万 - 项目类别:
X-linked Dyskeratosis Congenita and ribosomal frameshifting
X连锁先天性角化不良和核糖体移码
- 批准号:
8894573 - 财政年份:2014
- 资助金额:
$ 29.68万 - 项目类别:
Characterization of the SARSCoV frameshift signal
SARSCoV 移码信号的表征
- 批准号:
7884348 - 财政年份:2006
- 资助金额:
$ 29.68万 - 项目类别:
Characterization of the SARSCoV frameshift signal
SARSCoV 移码信号的表征
- 批准号:
7651192 - 财政年份:2006
- 资助金额:
$ 29.68万 - 项目类别:
Characterization of the SARS-CoV frameshift signal
SARS-CoV 移码信号的表征
- 批准号:
7253257 - 财政年份:2006
- 资助金额:
$ 29.68万 - 项目类别:
Characterization of the SARS-CoV frameshift signal
SARS-CoV 移码信号的表征
- 批准号:
7433287 - 财政年份:2006
- 资助金额:
$ 29.68万 - 项目类别:
Characterization of the SARSCoV frameshift signal
SARSCoV 移码信号的表征
- 批准号:
7139717 - 财政年份:2006
- 资助金额:
$ 29.68万 - 项目类别:
相似海外基金
Brief Transdiagnostic Treatment for Anxiety Disorders and PTSD in South Africa: A Hybrid-Effectiveness Trial
南非焦虑症和创伤后应激障碍的简短跨诊断治疗:混合有效性试验
- 批准号:
10369118 - 财政年份:2021
- 资助金额:
$ 29.68万 - 项目类别:
Brief Transdiagnostic Treatment for Anxiety Disorders and PTSD in South Africa: A Hybrid-Effectiveness Trial
南非焦虑症和创伤后应激障碍的简短跨诊断治疗:混合有效性试验
- 批准号:
10491868 - 财政年份:2021
- 资助金额:
$ 29.68万 - 项目类别: